Announces 2024 Platinum Ticket Investments and Opening of $4 Million 2025 Platinum Program Contest
Summary
MBCs Platinum Program aims to advance high-potential life sciences start-up companies by providing pre-seed funding, global laboratory space, expert mentorship, and discovery services to accelerate their launch and initial development. Deck Bio, based in LabCentral in Cambridge, MA, is developing optimal multi-specific biologics for driving durable efficacy and safety in solid tumors using its proprietary drug discovery platform. The Mission BioCapital Platinum Program is dedicated to identifying and accelerating biotechnology innovation, no matter where in the world it takes place, with the goal of turbocharging advancements in human health.The 2025 Platinum Program will award each of up to eight winning start-ups, including at least two European companies, with: A guaranteed lab bench in one of MBCs 24 affiliated incubators located in the U.S. and Europe Up to $500,000 of pre-seed capital from MBC, Lilly, and OVI Drug discovery services from Alloy Therapeutics and HitGen to enable companies with a derisked path to lead candidate General counsel, intellectual property, and accounting services from Goodwin, NMB IP, and van den Boom & Associates Strategic scientific and business development mentorship from experts at Lilly, OVI, Alloy Therapeutics, MBC, HitGen, and other companies across MBCs corporate networkMBC will be accepting applications between April 1 and May 14, 2025, and winners will be announced in Summer 2025. Platinum Program winners receive guaranteed laboratory space at MBCs partner incubators in the U.S. and Europe, access to world-class experts, lead candidate-enabling drug discovery services, and seed capital to quickly develop scientific data needed to obtain subsequent funding rounds. With offices in the nations leading life sciences clusters in Cambridge, MA and San Francisco, Mission BioCapital is dedicated to helping entrepreneurial scientists build successful companies, from idea to exit.